Yongyan Wu
0000-0003-1669-3860
Publication & Citation Trends
Most Cited Works
Publications
98 total
Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer PDF
Cited by 221
OpenAlex
Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target? PDF
Cited by 101
OpenAlex
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma PDF
Cited by 73
OpenAlex
circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway PDF
Cited by 176
OpenAlex
Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/PBX3 axis PDF
Cited by 150
OpenAlex
c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis PDF
Cited by 127
OpenAlex
Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1–AKT axis-mediated glycolysis PDF
Cited by 78
OpenAlex
Crosstalk between RNA m6A Modification and Non-coding RNA Contributes to Cancer Growth and Progression PDF
Cited by 76
OpenAlex
Research Topics
MicroRNA in disease regulation
(28)
Cancer-related molecular mechanisms research
(27)
Circular RNAs in diseases
(19)
Pluripotent Stem Cells Research
(17)
CRISPR and Genetic Engineering
(16)
Frequent Co-Authors
Affiliations
Shenzhen Institute of Information Technology
Shanxi Medical University
Shenzhen University
Shanxi University
Sir Run Run Shaw Hospital